Risk of cancer and serious disease in Danish patients with urgent referral for serious non-specific symptoms and signs of cancer in Funen 2014-2021
Authors:
- Rasmus Birkholm Grønnemose
- Per Syrak Hansen
- Søren Worsøe Laursen
- Oke Gerke
- Jakob Kjellberg
- Jesper Lykkegaard
- Clara Thye-Rønn
- Poul Flemming Høilund-Carlsen
- Per Thye-Rønn
Health
Health
BACKGROUND: In 2011, as the first European country, Denmark introduced the non-organ-specific cancer patient pathway (CPP) for patients presenting with non-specific symptoms and signs of cancer (NSSC). The proportion of patients with cancer over time is unknown.
METHODS: A retrospective cohort study of all patients with a NSSC-CPP investigational course in the province of Funen to the Diagnostic Centre in Svendborg from 2014 to 2021 was performed to evaluate the proportion of patients with cancer and serious disease over time.
RESULTS: A total of 6698 patients were referred to the NSSC-CPP of which 20.2% had cancer. While the crude referral rate increased from 114 per 100,000 people in 2014 and stabilised to around 214 in 2017-2021, the cancer detection rate of the total yearly new cancers in Funen diagnosed through the NSSC-CPP in DC Svendborg increased from 3 to 6%.
CONCLUSIONS: With now high and stable conversion and crude referral rates, the NSSC-CPP is one of the largest CPPs in Denmark as measured by the number of new cancer cases found. Similar urgent referral programmes in other countries might fill an unmet medical need for patients presenting with serious non-specific symptoms and signs of cancer in general practice.
Authors
- Rasmus Birkholm GrønnemosePer Syrak HansenSøren Worsøe LaursenOke GerkeJakob KjellbergJesper LykkegaardClara Thye-RønnPoul Flemming Høilund-CarlsenPer Thye-Rønn
About this publication
Published in
British Journal of Cancer